AAAAAA

   
Results: 1-7 |
Results: 7
Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation
Authors: van der Straaten, HM Fijnheer, R Dekker, AW Nieuwenhuis, HK Verdonck, LF
Citation: Hm. Van Der Straaten et al., Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation, BR J HAEM, 114(1), 2001, pp. 31-35
Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factorsdetermining outcome
Authors: Cornelissen, JJ Carston, M Kollman, C King, R Dekker, AW Lowenberg, B Anasetti, C
Citation: Jj. Cornelissen et al., Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factorsdetermining outcome, BLOOD, 97(6), 2001, pp. 1572-1577
Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients
Authors: van Kraaij, MGJ Dekker, AW Verdonck, LF van Loon, AM Vinje, J Koopmans, MPG Rozenberg-Arska, M
Citation: Mgj. Van Kraaij et al., Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients, BONE MAR TR, 26(3), 2000, pp. 299-303
No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients
Authors: Lagro, SWJ Verdonck, LF Rinkes, IHMB Dekker, AW
Citation: Swj. Lagro et al., No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients, BONE MAR TR, 26(10), 2000, pp. 1103-1106
Itraconazole oral solution for primary prophylaxis of fungal infections inpatients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazoleand amphotericin B
Authors: Harousseau, JL Dekker, AW Stamatoullas-Bastard, A Fassas, A Linkesch, W Gouveia, J De Bock, R Rovira, M Seifert, WF Joosen, H Peeters, M De Beule, K
Citation: Jl. Harousseau et al., Itraconazole oral solution for primary prophylaxis of fungal infections inpatients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazoleand amphotericin B, ANTIM AG CH, 44(7), 2000, pp. 1887-1893
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma
Authors: Segeren, CM Sonneveld, P van der Holt, B Baars, JW Biesma, DH Cornellissen, JJ Croockewit, AJ Dekker, AW Fibbe, WE Lowenberg, B Kooy, MV van Oers, MHJ Richel, DJ Schouten, HC Vellenga, E Verhoef, GEG Wijermans, PW Wittebol, S Lokhorst, HM
Citation: Cm. Segeren et al., Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma, BR J HAEM, 105(1), 1999, pp. 127-130
Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells
Authors: Verdonck, LF Petersen, EJ Lokhorst, HM Nieuwenhuis, HK Dekker, AW Tilanus, MGJ de Weger, RA
Citation: Lf. Verdonck et al., Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor Tcells, BONE MAR TR, 22(11), 1998, pp. 1057-1063
Risultati: 1-7 |